D4-105-01

N/A

Report date: 2025/06/11 10:21:10
NME

Base Information

Drug NameD4-105-01
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPost-Acute COVID-19 SyndromeFatigue Syndrome, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustria
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDelta 4 Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesDelta 4 Gmbh
Inactive CompaniesN/A
Active IndicationsPost-Acute COVID-19 SyndromeFatigue Syndrome, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A